N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide

Modify Date: 2025-08-20 09:53:35

N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide structure
 Common Name N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide
CAS Number 1005785-88-5 Molecular Weight 374.19
Density N/A Boiling Point N/A
Molecular Formula C15H12BrN5O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide

 Chemical & Physical Properties

Molecular Formula C15H12BrN5O2
Molecular Weight 374.19

 Preparation

O=C(Nc1cn2nc(Oc3cncc(Br)c3)ccc2n1)C1CC1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
1-Benzoylpiperidine-4-carbonitrile
198554-64-2
3-Bromo-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzyl alcohol
1980075-40-8
1-benzyl-6-bromo-3-ethyl-1H-indazole
215815-10-4
2-Nitro-6-(trifluoromethyl)phenacylamine hydrochloride
1980054-52-1
2-(2-Nitrophenyl)-1H-benzimidazole-7-methanol
273749-26-1
2-Bromo-3-nitrophenacylamine hydrochloride
1980062-67-6
N'-(4-bromo-2,6-dimethylphenyl)-N,N-dimethylimidoformamide
114886-15-6
5-Fluoro-2-(trifluoromethyl)phenacylamine hydrochloride
1980074-99-4
Pyridine, 4-[2-(4,5-diphenyl-1H-1,2,3-triazol-1-yl)ethyl]-
117377-85-2
5-Bromo-4-methoxy-2-(trifluoromethyl)-1H-benzimidazole
2090109-25-2
Chemsrc provides CAS#:1005785-88-5 MSDS, density, melting point, boiling point, structure, etc. Its name is N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide>> amp version: N-{6-[(5-bromopyridin-3-yl)oxy]imidazo[1,2-b]pyridazin-2-yl}cyclopropanecarboxamide

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved